InvestorsHub Logo

gutaquest

12/22/06 1:57 PM

#43686 RE: marcusaurelius #43677

MA, To compare the approval cycle of synDNA to an approval cycle for an antisense drug is not completely correct.

The synDNA is a mfg process for making plasmic DNA in a better manner than the presently used fermentation process.

What approval is required by the FDA is certainly a question to be answered. It is not a new molecular entity (NME).

I would like your opinion on what type of FDA approval cycle would be required for synDNA.

Gutaquest

david02835

12/22/06 5:47 PM

#43694 RE: marcusaurelius #43677

Marcus, and a good bit of holiday cheer to you as well. A nice holiday present from CYGX might be to tell the stockholders what the true time lines are for approvals and success of there products. My major gripe with this company all along has been with the communications to investors (which you have agreed is poor), with a minor gripe about semi-sleazy PPOs. I want synDNA to be the real thing for the good of mankind (corny I know, but true) and I would like to have a sound investment here as well. Is it required that I have a background in biotech to invest in a company like this? I own about 30 equities and I know more about this company than many of them because of this board and the mostly sincere and informative posters. I hope that this company makes it through January, however, and have sold off the rest of my shares. I will continue to watch and will jump back in when I see progress that I understand as a lay person in this industry. Take care and please help the rest of us the best you can. Your post are very helpful, more so when you are not angry (same here) LOL!